Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Voxzogo189.79M25.45%
Vimizim178.16M23.89%
Naglazyme131.91M17.69%
Palynziq90.63M12.15%
ALDURAZYME71.03M9.52%
Brineura37.01M4.96%
Kuvan28.12M3.77%
Royalty and other revenues11.87M1.59%
ROCTAVIAN7.24M0.97%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States771.31M31.88%
Europe669.33M27.67%
Rest of world468.21M19.35%
Latin America332.44M13.74%
Aldurazyme net product revenues marketed by Sanofi131.25M5.43%
Royalty and other revenues46.69M1.93%
View all
